CRIS Current Research Information System

IMBROGNO, ENRICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.470
AS - Asia 1.339
EU - Europa 1.013
AF - Africa 84
SA - Sud America 46
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.954
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.449
VN - Vietnam 473
SG - Singapore 349
CN - Cina 247
GB - Regno Unito 224
DE - Germania 127
IT - Italia 122
SE - Svezia 119
CH - Svizzera 86
HK - Hong Kong 83
IN - India 69
FR - Francia 63
NL - Olanda 56
RU - Federazione Russa 43
IE - Irlanda 37
BR - Brasile 31
CI - Costa d'Avorio 31
JP - Giappone 31
FI - Finlandia 25
BG - Bulgaria 21
ZA - Sudafrica 21
EE - Estonia 20
BE - Belgio 19
PH - Filippine 17
TG - Togo 15
UA - Ucraina 15
CA - Canada 12
BD - Bangladesh 11
PL - Polonia 10
TH - Thailandia 10
JO - Giordania 8
NG - Nigeria 7
IQ - Iraq 6
KR - Corea 6
AR - Argentina 5
GR - Grecia 5
UZ - Uzbekistan 5
AT - Austria 4
DZ - Algeria 4
ES - Italia 4
TW - Taiwan 4
CL - Cile 3
HR - Croazia 3
ID - Indonesia 3
IR - Iran 3
MX - Messico 3
PY - Paraguay 3
SC - Seychelles 3
TR - Turchia 3
CZ - Repubblica Ceca 2
EC - Ecuador 2
JM - Giamaica 2
KZ - Kazakistan 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
AO - Angola 1
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
TM - Turkmenistan 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 3.954
Salva come PNG Salva come JPEG
Città #
Singapore 257
Southend 199
Ashburn 184
Chandler 136
Dong Ket 133
Fairfield 111
Bern 81
San Jose 80
Ann Arbor 78
Hong Kong 78
Hanoi 72
Wilmington 71
Houston 69
Ho Chi Minh City 66
Woodbridge 61
Seattle 57
Beijing 54
Cambridge 40
Princeton 40
Dublin 37
Santa Clara 36
Boardman 34
Abidjan 31
Tokyo 24
Sofia 21
Bologna 20
Lauterbourg 20
New York 20
Westminster 20
Brussels 19
Padova 19
Helsinki 18
Los Angeles 17
Nanjing 17
Berlin 16
Da Nang 15
Haiphong 15
Lomé 15
Munich 15
Dallas 14
Frankfurt am Main 14
Jinan 14
Falls Church 13
Medford 13
Saint Petersburg 13
Buffalo 10
Nanchang 10
Hyderabad 9
Mountain View 9
Paris 9
Redwood City 9
Shenyang 9
Council Bluffs 8
Florence 8
Guangzhou 8
London 8
Pune 8
Shanghai 8
São Paulo 8
Warsaw 8
Amman 7
Bremen 7
Turku 7
Abeokuta 6
Atlanta 6
Changsha 6
Hebei 6
Jiaxing 6
Redmond 6
Amsterdam 5
Chicago 5
Fuzhou 5
Hangzhou 5
Hải Dương 5
Montreal 5
Norwalk 5
Redondo Beach 5
Turin 5
Augusta 4
Bangkok 4
Biên Hòa 4
Brooklyn 4
Ninh Bình 4
Orem 4
Quezon City 4
San Diego 4
San Francisco 4
Seoul 4
Taiyuan 4
Athens 3
Baghdad 3
Bình Phước 3
Chennai 3
Falkenstein 3
Nha Trang 3
Phoenix 3
Reggio Emilia 3
Rome 3
Stockholm 3
Tianjin 3
Totale 2.685
Salva come PNG Salva come JPEG
Nome #
Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization 324
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 254
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 237
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 222
Inhibition of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) is a novel therapeutic strategy in B- and T-Acute Lymphoblastic Leukemia (ALL). 214
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma 210
RALE051: a novel established cell line of sporadic Burkitt lymphoma 209
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 209
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia 196
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 192
The synergistic efficacy of Chk1/Chk2 inhibitors and doxorubicin in the treatment of acute lymphoblastic leukemia 185
Enhance the Efficacy of Doxorubicin Destabilizing the G2/M Checkpoint with a CHK1/CHK2 Inhibitor Pre-Treatment on Acute Lymphoblastic Leukemia 178
Clec12a: A new AML stem cell-associated antigen 177
RNA Sequencing Reveals Novel and Rare Fusion Transcripts in Acute Myeloid Leukemia 174
Override the doxorubicin-induced G2/M checkpoint using cell-cycle checkpoint inhibitors on acute lymphoblastic leukemia 169
The Inhibition of Checkpoint Kinase 1 As a Promising Strategy to Increase the Effectiveness of Different Treatments in Acute Lymphoblastic Leukemia 164
You have accessMine the Stability of the G2/M Checkpoint to Break Down Acute Lymphoblastic Leukemia Defenses Against Antineoplastic Drugs 158
Novel fusion transcripts identified by RNAseq cooperate with somatic mutations in the pathogenesis of acute myeloid leukemia 154
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate 141
null 101
Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma 90
null 75
Totale 4.033
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021167 0 0 0 0 0 0 0 0 0 0 0 167
2021/2022485 74 18 23 33 46 29 13 26 20 38 81 84
2022/2023606 74 68 26 75 37 34 13 24 83 17 46 109
2023/2024165 11 16 9 19 12 45 7 16 6 6 4 14
2024/2025479 25 61 41 41 49 15 33 22 1 65 15 111
2025/20261.187 101 58 54 71 120 75 138 48 371 107 26 18
Totale 4.033